Latest news and press releases about Inspira Technologies OXY B.H.N. Ltd. (IINN): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less.
Price
| Price | $1.05 |
| Market Cap | $25M |
| Exchange | NASDAQ |
| Country | IL |
Valuation Ratios
| Price / Book | 12.11 |
| EV / EBITDA | -1.90 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -569.09% |
| Return on Invested Capital | -326.40% |
| Return on Assets | -247.52% |
| Gross Margin | 0.69% |
| Operating Margin | 2503.46% |
| Net Margin | -2213.84% |
Related companies: BFRI · ENSC · FEED · HSCS · ISPC · PTPI · RPID
Explore sector: Healthcare · Medical - Devices
More sections of IINN: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks